Bone, Henry G <br/><br/>
10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension.  [electronic resource] 

 -  The lancet. Diabetes & endocrinology  07 2017 
 - 513-523 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2213-8595 
<br/><br/><label>Standard No.: </label>10.1016/S2213-8587(17)30138-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Bone Density--drug effects<br/>Bone Density Conservation Agents--therapeutic use<br/>Cross-Over Studies<br/>Denosumab--therapeutic use<br/>Double-Blind Method<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Middle Aged<br/>Osteoporosis, Postmenopausal--drug therapy<br/>Prognosis<br/>Time Factors